ProCE Banner Activity

Prurigo Nodularis: A Look at What’s To Come

Slideset

Download these slides for an expert review of the diagnosis and treatment, including current and promising investigational therapies, for prurigo nodularis.

Released: September 09, 2022

Expiration: September 08, 2023

Share

Acknowledgement

This program is supported by educational grants from Boehringer Ingelheim Pharmaceuticals, Inc.; Incyte Corporation; Novartis Pharmaceuticals Corporation; and Sanofi and Regeneron Pharmaceuticals.

Disclosure

Benjamin Ungar, MD: consultant/advisor/speaker: Arcutis, Castle Biosciences; researcher: Incyte, Pfizer, Rapt Therapeutics

 
 


 

Additional Information

Program Medium

This program has been made available online.